Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Tularemia is an infection caused by the bacterium Francisella tularensis. It is more common in rodents and rabbits but has been found in other animals including domestic cats, sheep, birds, and hamsters. Humans can become infected in several different ways: by handling infected animals, through tick or deer fly bites, by drinking contaminated water, or by inhaling contaminated dust or aerosols. Person-to-person transmission has not been reported. The type of tularemia and the particular signs and symptoms vary depending on how the bacteria enter the body. However, fever is seen in most cases. Though tularemia can be life-threatening, most infections can be treated with antibiotics.
Biomarker and diagnostic research for tularemia has been reported in the published literature.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
1 clinical trial registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
301 publications have been identified in PubMed for tularemia. Kisho has analyzed 201 by research type. Research spans Basic Science / Preclinical (28%), Case Report / Case Series (27%), and Epidemiology / Natural History (25%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 56 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 7:12 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies | 55 | 27% |
Disease patterns and progression | 50 | 25% |
Research summaries | 18 | 9% |
New treatment approaches | 11 | 5% |
Testing and diagnosis research | 6 | 3% |
Clinical study results | 3 | 1% |
Other research | 2 | 1% |
Dar A (2026). [PMID: 41776129](https://pubmed.ncbi.nlm.nih.gov/41776129/). *Journal of hematopathology*. [Case Report / Case Series]
Klima M (2026). [PMID: 42049235](https://pubmed.ncbi.nlm.nih.gov/42049235/). *Nucleic Acids Res*. [Basic Science / Preclinical]
Bachert BA (2026). [PMID: 42140512](https://pubmed.ncbi.nlm.nih.gov/42140512/). *Anal Biochem*. [Basic Science / Preclinical]
Siller A (2026). [PMID: 41241135](https://pubmed.ncbi.nlm.nih.gov/41241135/). *International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases*. [Epidemiology / Natural History]
Zaghdoudi A (2026). [PMID: 41482246](https://pubmed.ncbi.nlm.nih.gov/41482246/). *International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases*. [Epidemiology / Natural History]
Manucharyan A (2026). [PMID: 41123448](https://pubmed.ncbi.nlm.nih.gov/41123448/). *Vector Borne Zoonotic Dis*. [Epidemiology / Natural History]
Van Horn CM (2026). [PMID: 41979023](https://pubmed.ncbi.nlm.nih.gov/41979023/). *ACS Infect Dis*. [Basic Science / Preclinical]
Hahn C (2026). [PMID: 41577889](https://pubmed.ncbi.nlm.nih.gov/41577889/). *Infection*. [Case Report / Case Series]
Songin B (2026). [PMID: 41725338](https://pubmed.ncbi.nlm.nih.gov/41725338/). *Praxis (Bern 1994)*. [Review / Meta-Analysis]
Khademi Baneh N (2026). [PMID: 41620757](https://pubmed.ncbi.nlm.nih.gov/41620757/). *BMC Vet Res*. [Basic Science / Preclinical]
AI-curated news mentioning tularemia
Updated Aug 1, 2026
A recent study highlights pediatric tularemia as a neglected disease in Denmark, emphasizing the need for increased awareness and research. The findings suggest that this infectious disease, caused by the bacterium Francisella tularensis, may be underdiagnosed in children.
A case study highlights a patient with pulmonary tularemia experiencing a relapse of tularemia orchitis while on a TNF-alpha inhibitor. This finding underscores the potential risks associated with immunosuppressive therapies in rare infectious diseases.
A recent study published in PubMed details the histopathologic findings associated with tularemia lymphadenitis. This research enhances understanding of the disease's pathology, which may inform future diagnostic and therapeutic strategies.